Detalhe da pesquisa
1.
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
Blood
; 2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493484
2.
Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Transfusion
; 63(11): 2131-2139, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850414
3.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol
; 102(3): 547-561, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695874
4.
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
Transfusion
; 62(1): 157-164, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893987
5.
Analysis of stem cell collections in adult patients with Ewing sarcoma.
Transfusion
; 62(8): 1612-1618, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35801531
6.
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 96(10): 1287-1294, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289154
7.
Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
Ann Hematol
; 99(10): 2417-2427, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862286
8.
Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy.
Curr Treat Options Oncol
; 21(1): 8, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002673
9.
Pretreatment CD34+/CD38- Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1560-1566, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928626
10.
Comparison of non-myeloablative and reduced-intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes.
Am J Hematol
; 94(12): 1344-1352, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495933
11.
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
Ann Hematol
; 97(10): 1757-1765, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785446
12.
Outcome prediction by the knowledge bank approach in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 97(10): E382-E384, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802783
13.
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation.
Am J Hematol
; 92(4): 388-396, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28133783
14.
Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 96(7): E237-E239, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811773
15.
High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population.
Haematologica
; 105(10): e507, 2020 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054093
16.
Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
Pediatr Blood Cancer
; 62(5): 823-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623397
17.
Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation.
Int J Cardiol Heart Vasc
; 51: 101383, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496258
18.
Management of Patients Undergoing CAR-T Cell Therapy in Germany.
Oncol Res Treat
; 47(3): 65-75, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198763
19.
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
Leukemia
; 38(2): 372-382, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184754
20.
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries.
Leukemia
; 38(4): 810-821, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448757